Scientists report that halting production of synaptotagmin 17 (syt-17) blocks growth of axons. Equally significant, when cells made more syt-17, axon growth accelerated. A wide range of neurological conditions could benefit from the growth of axons, including spinal cord injuries and some neurodegenerative diseases.